Literature DB >> 18042933

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.

Vasundara Venkateswaran1, Ahmed Q Haddad, Neil E Fleshner, Rong Fan, Linda M Sugar, Rob Nam, Laurence H Klotz, Michael Pollak.   

Abstract

BACKGROUND: Prior research suggested that energy balance and fat intake influence prostate cancer progression, but the influence of dietary carbohydrate on prostate cancer progression has not been well characterized. We hypothesized that hyperinsulinemia resulting from high intake of refined carbohydrates would lead to more rapid growth of tumors in the murine LNCaP xenograft model of prostate cancer.
METHODS: Athymic mice were injected subcutaneously with LNCaP human prostate cancer cells and, when tumors were palpable, were randomly assigned (n = 20 per group) to high carbohydrate-high fat or low carbohydrate-high fat diets. Body weight and tumor volume were measured weekly. After 9 weeks, serum levels of insulin and insulin-like growth factor 1 (IGF-1) were measured by enzyme immunoassay. AKT activation and the levels of the insulin receptor in tumor cells were determined by immunoblotting. The in vitro growth response of LNCaP cells to serum from mice in the two treatment groups was measured based on tetrazolium compound reduction. All statistical tests were two-sided.
RESULTS: After 9 weeks on the experimental diets, mice on the high carbohydrate-high fat diet were heavier (mean body weight of mice on the high carbohydrate-high fat diet = 34 g versus 29.1 g on the low carbohydrate-high fat diet, difference = 4.9 g, 95% CI = 3.8 to 6.0 g; P = .003), experienced increased tumor growth (mean tumor volume in mice on high carbohydrate-high fat diet = 1695 versus 980 mm3 on low carbohydrate-high fat diet, difference = 715 mm3, 95% CI = 608 to 822 mm3; P<.001), and experienced a statistically significant increase in serum insulin and IGF-1 levels. Tumors from mice on the high carbohydrate-high fat diet had higher levels of activated AKT and modestly higher insulin receptor levels than tumors from mice on the low carbohydrate-high fat diet. Serum from mice on the high carbohydrate-high fat diet was more mitogenic for LNCaP cells in vitro than serum from mice fed the low carbohydrate-high fat diet.
CONCLUSION: A diet high in refined carbohydrates is associated with increased tumor growth and with activation of signaling pathways distal to the insulin receptor in a murine model of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042933     DOI: 10.1093/jnci/djm231

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  59 in total

1.  Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.

Authors:  Danielle B Ulanet; Dale L Ludwig; C Ronald Kahn; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 2.  Potential applications for biguanides in oncology.

Authors:  Michael Pollak
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

3.  Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?

Authors:  Hua Xu; Meng-Bo Hu; Pei-de Bai; Wen-Hui Zhu; Qiang Ding; Hao-Wen Jiang
Journal:  Int Urol Nephrol       Date:  2014-08-27       Impact factor: 2.370

4.  Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Marian L Neuhouser; Cathee Till; Alan Kristal; Phyllis Goodman; Ashraful Hoque; Elizabeth A Platz; Ann W Hsing; Demetrius Albanes; Howard L Parnes; Michael Pollak
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

5.  Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model.

Authors:  Jessica C Lloyd; Jodi A Antonelli; Tameika E Phillips; Elizabeth M Masko; Jean-Alfred Thomas; Susan H M Poulton; Michael Pollak; Michael Pollack; Stephen J Freedland
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

Review 6.  Highlights of the university of toronto urology update 2014.

Authors:  Sender Herschorn
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

7.  Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer.

Authors:  Lora S Wang; Colin T Murphy; Karen Ruth; Nicholas G Zaorsky; Marc C Smaldone; Mark L Sobczak; Alexander Kutikov; Rosalia Viterbo; Eric M Horwitz
Journal:  Cancer       Date:  2015-05-29       Impact factor: 6.860

8.  The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model.

Authors:  Jorge Caso; Elizabeth M Masko; Jean A Thomas Ii; Susan H Poulton; Mark Dewhirst; Salvatore V Pizzo; Stephen J Freedland
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

Review 9.  The emerging role of obesity, diet and lipid metabolism in prostate cancer.

Authors:  Matteo Ferro; Daniela Terracciano; Carlo Buonerba; Giuseppe Lucarelli; Danilo Bottero; Sisto Perdonà; Riccardo Autorino; Alessandro Serino; Francesco Cantiello; Rocco Damiano; Iulia Andras; Sabino De Placido; Giuseppe Di Lorenzo; Michele Battaglia; Barbara A Jereczek-Fossa; Vincenzo Mirone; Ottavio De Cobelli
Journal:  Future Oncol       Date:  2016-09-14       Impact factor: 3.404

10.  Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway.

Authors:  S Eliasz; S Liang; Y Chen; M A De Marco; O Machek; S Skucha; L Miele; M Bocchetta
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.